Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | LB1908 |
Trade Name | |
Synonyms | LB-1908|LB 1908 |
Drug Descriptions |
LB1908 are autologous T-cells engineered to express a chimeric antigen receptor (CAR) targeting Claudin 18.2 (CLDN18.2), which potentially induce toxicity in tumor cells expressing CLDN18.2 (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C192206 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
LB1908 | LB1908 | 0 | 1 |